Myles Minter
Stock Analyst at William Blair
(1.88)
# 3,248
Out of 5,113 analysts
23
Total ratings
52.94%
Success rate
0.62%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Myles Minter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRRO Korro Bio | Downgrades: Market Perform | n/a | $10.73 | - | 2 | Nov 13, 2025 | |
| BHVN Biohaven | Downgrades: Market Perform | n/a | $13.51 | - | 1 | Nov 5, 2025 | |
| ALEC Alector | Downgrades: Market Perform | n/a | $1.94 | - | 2 | Oct 22, 2025 | |
| DNTH Dianthus Therapeutics | Initiates: Outperform | n/a | $52.33 | - | 1 | Jul 2, 2025 | |
| IMUX Immunic | Initiates: Outperform | n/a | $0.69 | - | 1 | Mar 25, 2025 | |
| CAMP Camp4 Therapeutics | Initiates: Outperform | n/a | $4.01 | - | 1 | Nov 5, 2024 | |
| ARGX argenx SE | Upgrades: Outperform | n/a | $814.74 | - | 2 | Nov 1, 2024 | |
| NMRA Neumora Therapeutics | Initiates: Outperform | n/a | $2.06 | - | 1 | Oct 10, 2023 | |
| ARCT Arcturus Therapeutics Holdings | Initiates: Outperform | $71 | $7.53 | +842.90% | 1 | Jul 24, 2023 | |
| MRNA Moderna | Initiates: Market Perform | n/a | $48.71 | - | 1 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $468.41 | - | 1 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $311.71 | - | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $3.69 | - | 3 | Sep 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $357.98 | - | 1 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $80.29 | - | 2 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $116 | $136.18 | -14.82% | 1 | Feb 24, 2020 |
Korro Bio
Nov 13, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $10.73
Upside: -
Biohaven
Nov 5, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $13.51
Upside: -
Alector
Oct 22, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $1.94
Upside: -
Dianthus Therapeutics
Jul 2, 2025
Initiates: Outperform
Price Target: n/a
Current: $52.33
Upside: -
Immunic
Mar 25, 2025
Initiates: Outperform
Price Target: n/a
Current: $0.69
Upside: -
Camp4 Therapeutics
Nov 5, 2024
Initiates: Outperform
Price Target: n/a
Current: $4.01
Upside: -
argenx SE
Nov 1, 2024
Upgrades: Outperform
Price Target: n/a
Current: $814.74
Upside: -
Neumora Therapeutics
Oct 10, 2023
Initiates: Outperform
Price Target: n/a
Current: $2.06
Upside: -
Arcturus Therapeutics Holdings
Jul 24, 2023
Initiates: Outperform
Price Target: $71
Current: $7.53
Upside: +842.90%
Moderna
Jul 24, 2023
Initiates: Market Perform
Price Target: n/a
Current: $48.71
Upside: -
May 30, 2023
Initiates: Outperform
Price Target: n/a
Current: $468.41
Upside: -
Mar 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $311.71
Upside: -
Sep 19, 2022
Upgrades: Outperform
Price Target: n/a
Current: $3.69
Upside: -
Jun 7, 2022
Initiates: Outperform
Price Target: n/a
Current: $357.98
Upside: -
Dec 14, 2021
Upgrades: Outperform
Price Target: n/a
Current: $80.29
Upside: -
Feb 24, 2020
Initiates: Outperform
Price Target: $116
Current: $136.18
Upside: -14.82%